Document
type: Class

4698812
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers
type: Academic Article
type: Information Content Entity
type: Thing
language: Inglese
type: Article
related by: 4698812
type: Generically Dependent Continuant
type: Entity
most specific type: Academic Article
type: Document
type: Continuant
related by: 12470517

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-25T02:54:15
publisher: A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers
type: Document
label: RDF description of A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers - http://irises.unibs.it/resource/item/82044

Article
type: Class

Information Content Entity
type: Class

12470517
type: Entity
type: BFO_0000020
type: Relationship
type: Continuant
type: Thing
relates: A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers